HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhi-Gang Jiang Selected Research

3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)

1/2018PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
1/2016PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth.
1/2009PAN-811 inhibits oxidative stress-induced cell death of human Alzheimer's disease-derived and age-matched olfactory neuroepithelial cells via suppression of intracellular reactive oxygen species.
7/2007PAN-811 provides neuroprotection against glutamate toxicity by suppressing activation of JNK and p38 MAPK.
1/2006A multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.
1/2006Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhi-Gang Jiang Research Topics

Disease

8Neoplasms (Cancer)
01/2019 - 01/2006
3Neoplasm Metastasis (Metastasis)
01/2019 - 09/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2013 - 01/2006
2Cognitive Dysfunction
01/2018 - 01/2016
2Chemotherapy-Related Cognitive Impairment
01/2018 - 01/2016
1Breast Neoplasms (Breast Cancer)
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Adenocarcinoma
01/2019
1Cytomegalovirus Infections (Inclusion Disease)
11/2010
1Infections
11/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2009
1Amyloid Plaque
01/2009
1Hypoglycemia (Reactive Hypoglycemia)
07/2007
1Hypoxia (Hypoxemia)
07/2007
1Ischemic Stroke
01/2006
1Infarction (Infarctions)
01/2006
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2006

Drug/Important Bio-Agent (IBA)

63-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
01/2018 - 01/2006
5Pharmaceutical PreparationsIBA
01/2018 - 01/2006
3Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2018 - 01/2006
3Neuroprotective AgentsIBA
01/2016 - 01/2006
2DNA (Deoxyribonucleic Acid)IBA
11/2010 - 01/2006
1Proteins (Proteins, Gene)FDA Link
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Aspartic Acid (Aspartate)FDA Link
01/2019
1src-Family KinasesIBA
01/2019
1Mixed Function Oxygenases (Monooxygenases)IBA
01/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
01/2019
1Long-Acting Thyroid Stimulator (LATS)IBA
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
01/2016
1Transcription Factors (Transcription Factor)IBA
09/2012
1brincidofovirIBA
11/2010
1EstersIBA
11/2010
1LipidsIBA
11/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2009
1Amyloid beta-PeptidesIBA
01/2009
1Glutamic Acid (Glutamate)FDA Link
07/2007
1VeratridineIBA
07/2007
1StaurosporineIBA
07/2007
1EnzymesIBA
01/2006

Therapy/Procedure

4Therapeutics
01/2019 - 01/2006
3Drug Therapy (Chemotherapy)
01/2018 - 12/2013